These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 24406736)

  • 21. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pegylated interferon (alone or with ribavirin) for chronic hepatitis C in haemodialysis population.
    Espinosa M; Hernàndez J; Arenas MD; Carnicer F; Caramelo C; Fabrizi F
    Kidney Blood Press Res; 2015; 40(3):258-65. PubMed ID: 25997572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy.
    Momattin H; Mohammed K; Zumla A; Memish ZA; Al-Tawfiq JA
    Int J Infect Dis; 2013 Oct; 17(10):e792-8. PubMed ID: 23993766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta-analysis.
    Morra ME; Van Thanh L; Kamel MG; Ghazy AA; Altibi AMA; Dat LM; Thy TNX; Vuong NL; Mostafa MR; Ahmed SI; Elabd SS; Fathima S; Le Huy Vu T; Omrani AS; Memish ZA; Hirayama K; Huy NT
    Rev Med Virol; 2018 May; 28(3):e1977. PubMed ID: 29664167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C.
    You BC; Kim YS; Kim Hi; Kim SH; Park SS; Seo YR; Kim SG; Lee SW; Kim HS; Jeong SW; Jang JY; Kim BS
    Clin Mol Hepatol; 2012 Sep; 18(3):272-8. PubMed ID: 23091807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re-treatment with peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapy.
    Yoshida EM; Sherman M; Bain VG; Cooper CL; Deschênes M; Marotta PJ; Lee SS; Krajden M; Witt-Sullivan H; Bailey RJ; Usaty C; Peltekian K;
    Can J Gastroenterol; 2009 Mar; 23(3):180-4. PubMed ID: 19319382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute Management and Long-Term Survival Among Subjects With Severe Middle East Respiratory Syndrome Coronavirus Pneumonia and ARDS.
    Khalid I; Alraddadi BM; Dairi Y; Khalid TJ; Kadri M; Alshukairi AN; Qushmaq IA
    Respir Care; 2016 Mar; 61(3):340-8. PubMed ID: 26701365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.
    Hui DS; Memish ZA; Zumla A
    Curr Opin Pulm Med; 2014 May; 20(3):233-41. PubMed ID: 24626235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical features and treatment outcome of chronic hepatitis C with pegylated interferon and ribavirin in routine care.
    Tan SS; Adlin Nadia Z
    Med J Malaysia; 2017 Jun; 72(3):165-174. PubMed ID: 28733564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum KL-6 level is elevated in chronic hepatitis C patients with combination therapy of pegylated interferon and ribavirin.
    Arase Y; Ikeda K; Suzuki Y; Kobayashi M; Suzuki F; Akuta N; Sezaki H; Hosaka T; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
    Intern Med; 2007; 46(15):1155-60. PubMed ID: 17675762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome.
    Kain T; Lindsay PJ; Adhikari NKJ; Arabi YM; Van Kerkhove MD; Fowler RA
    Emerg Infect Dis; 2020 Jun; 26(6):1102-1112. PubMed ID: 32213260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is combination therapy interferon and ribavirin in patients with chronic hepatitis C infection toxic for eyes?
    Mousa N; Besheer T; Gad Y; Elbendary A; Mokbel T; Abdel-Aziz A
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):345-8. PubMed ID: 23113644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-dose infliximab in hepatitis C genotype 1 treatment-naive patients with high serum tumour necrosis factor-alpha does not influence the efficacy of pegylated interferon alpha-2b/ribavirin therapy.
    Cooper C; Shafran S; Greenbloom S; Enns R; Farley J; Hilzenrat N; Williams K; Elkashab M; Abadir N; Neuman M
    Can J Gastroenterol Hepatol; 2014 Jan; 28(1):35-40. PubMed ID: 24212915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Emergency treatment for Middle Eastern coronaviruses (MERS-CoV].
    Nau JY
    Rev Med Suisse; 2013 Jun; 9(392):1394-5. PubMed ID: 23882919
    [No Abstract]   [Full Text] [Related]  

  • 35. Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype.
    Itokawa N; Atsukawa M; Tsubota A; Kondo C; Hashimoto S; Fukuda T; Matsushita Y; Kidokoro H; Kobayashi T; Narahara Y; Nakatsuka K; Kanazawa H; Iwakiri K; Sakamoto C
    J Gastroenterol Hepatol; 2013 Mar; 28(3):443-9. PubMed ID: 23173698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role and possibilities of natural interferon treatment in chronic hepatitis C: experience with natural interferon treatment for patients barred from combined antiviral therapy because of the STOP rule].
    Horváth G; Tolvaj G; Halász T; Stotz G
    Orv Hetil; 2007 Aug; 148(33):1545-50. PubMed ID: 17686672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral Ribavirin for the Treatment of Noninfluenza Respiratory Viral Infections: A Systematic Review.
    Gross AE; Bryson ML
    Ann Pharmacother; 2015 Oct; 49(10):1125-35. PubMed ID: 26228937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to pegylated interferon alpha-2b and ribavirin in children with chronic hepatitis C.
    Baker RD; Dee D; Baker SS
    J Clin Gastroenterol; 2007 Jan; 41(1):111-4. PubMed ID: 17198073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response.
    Neukam K; Barreiro P; Rivero-Juárez A; Caruz A; Mira JA; Camacho A; Macías J; Rivero A; Soriano V; Pineda JA
    J Infect; 2013 Jul; 67(1):59-64. PubMed ID: 23542783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy.
    Myers RP; Benhamou Y; Bochet M; Thibault V; Mehri D; Poynard T
    AIDS; 2004 Jan; 18(1):75-9. PubMed ID: 15090832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.